Form 4: Repare Therapeutics SVP, Finance and CAO, Sandra Alves, Reports Acquisition of Stock Options and Restricted Stock Units

Sandra Isabelle Barros Alves, SVP, Finance and CAO of Repare Therapeutics Inc., reports the acquisition of stock options and restricted stock units.

Summary

• On April 2, 2025, Sandra Isabelle Barros Alves, SVP, Finance and CAO of Repare Therapeutics Inc., reported acquiring 4,100 common shares in the form of restricted stock units (RSUs) and 24,500 employee stock options.
• The RSUs will vest on April 2, 2026, contingent upon continued service.
• The stock options, with an exercise price of $1.07, also vest fully on April 2, 2026, subject to continued service, and expire on April 1, 2035.
• Following these transactions, Alves directly owns 29,622 common shares and 24,500 derivative securities (employee stock options).

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine disclosure of stock options and restricted stock units granted to an executive. It indicates alignment of interests but doesn't inherently suggest positive or negative performance.

Positives

• The acquisition of RSUs and stock options aligns the executive's interests with those of the shareholders.
• The vesting schedules incentivize continued service and commitment to the company's long-term success.

Industry Context

Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to monitor executive compensation and alignment with shareholder interests.

Comparison to Industry Standards

• Stock option and RSU grants are a common form of executive compensation in the biotechnology industry, used to attract and retain talent.
• Vesting schedules, typically over a period of 1-4 years, are standard practice to incentivize long-term commitment.
• The specific terms of the grants (e.g., vesting date, exercise price) would need to be compared to those of peer companies to assess their competitiveness.

Stakeholder Impact

• The acquisition of stock options and RSUs by a key executive can positively influence shareholder sentiment by aligning management's interests with those of the shareholders.
• Employees may view this as a positive sign of company stability and growth potential.

Key Dates

Keywords

Repare Therapeutics, Sandra Alves, Form 4, Stock Options, Restricted Stock Units, Beneficial Ownership, Insider Trading